• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

genetic engineering

Small white blocks with black text that say Diabetes Type 1 in all caps surrounded by syringes containing a blue liquid th
Research

Sana's engineered islet cells control glucose in diabetic monkey

The transplanted islet cells controlled the animal's glucose levels for six months without the need for insulin or immunosuppression.
Helen Floersh Feb 15, 2024 2:55pm
Coronavirus Piggy Bank

United Therapeutics buys Miromatrix in $91M xenotransplant deal

Oct 30, 2023 10:45am
A graphic displaying a cross-section of the kidneys

Revivicor sees 61 days' function in kidney+thymus xenotransplant

Sep 25, 2023 9:45am
Mouse

Injected 'dancing molecules' restore mobility in paralyzed mice

Nov 15, 2021 9:35am
Mekonos cell engineering

Novartis-backed Mekonos nets $25M for cell engineering platform

Nov 9, 2021 11:00am
CRISPR technology for genome editing Source AstraZeneca

Inscripta racks up $150M round alongside commercial launch

Apr 5, 2021 3:30pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings